AI-generated summary
The authors report on a single-arm open-label trial of four weeks of morning bright light therapy delivered through light glasses, added to usual treatment for 39 depressed adolescent inpatients. Depressive symptoms, sleep problems and clinical global impression improved significantly, and the authors describe the glasses as feasible and well accepted. Because the design had no control arm, the authors state that randomized controlled trials are still needed.
- Participants
- 39
- Who or what was studied
- Adolescent inpatients aged 12-18 years with moderate or severe depression
- Limits stated in the abstract
- The study was open-label, single-arm and without a control group, and the authors state that randomized controlled trials are needed to establish efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on econtent.hogrefe.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.